The hypotheses to be tested are 1) Fiber supplementation will decrease the need for medication in patients with gestational diabetes, and 2) Fiber supplementation will decrease adverse maternal and neonatal outcomes in these patients. In this study, the investigators will conduct a randomized controlled trial to limit bias in evaluating these hypotheses.
Singleton gestation
Known or new diagnosis of gestational diabetes without reason for medication
Age >=18 to <=50
- Non-English as primary language.
Known or suspected fetal anomaly or aneuploidy.
Known lower bowel disorder
Known phenylketonuria